Re7 Labs
DeFi Research and Development Company
Buổi biểu diễn
Chỉ số Phổ Biến RD
Chỉ số Tăng Trưởng RD
Thu nhập và đốt token
Thu nhập giao thức
$1.96KVốn mua lại
--Vốn đốt token
--Tỷ lệ mua lại
--Xu hướng dòng tiền giao thức
Số tiền và tỷ lệ · Hàng tháng
| Kỳ | Thu nhập giao thức | Vốn mua lại | Vốn đốt token | Tỷ lệ mua lại |
|---|---|---|---|---|
| Nov 2026 | $1.96K | -- | -- | -- |
| Oct 2026 | $15.67K | -- | -- | -- |
| Sep 2026 | $13.34K | -- | -- | -- |
| Aug 2026 | $9.19K | -- | -- | -- |
| Jul 2026 | $8.27K | -- | -- | -- |
| Jun 2026 | $7.21K | -- | -- | -- |
So sánh
Về Re7 Labs
Re7 Labs is the research and risk arm of London-based asset manager Re7 Capital, focused mainly on curating on-chain vaults: it opens MetaMorpho vaults on Morpho Blue, sets acceptable collateral, loan-to-value ceilings and market quotas, then allocates capital across lending markets; it also runs restaking vaults on Mellow and Symbiotic and issues yield tokens through Midas. Its target problem is the outsourcing of parameter governance: once lending markets can be created permissionlessly, who sets the collateral list and liquidation thresholds, and by what standard they are adjusted, determines how losses are distributed among depositors.
In category terms it sits in DeFi credit and vault management, serving depositors who want institutional-grade risk screening and institutions that need a stable borrowing source. Internally it scores protocols and counterparties against a rating framework, sets limits and concentration caps from those scores, and keeps monitoring on-chain anomalies before adjusting allocations. In the first half of 2026, deposit rates across several major lending pools fell to levels that no longer covered contract risk, and allocations in some pools were cut accordingly.